Bersanlimab

CAS No. 1987854-08-9

Bersanlimab( —— )

Catalog No. M36775 CAS No. 1987854-08-9

Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1), demonstrating anticancer properties and applicable for studying relapsed/refractory multiple myeloma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 655 In Stock
10MG 1017 In Stock
25MG 1511 In Stock
50MG 2000 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bersanlimab
  • Note
    Research use only, not for human use.
  • Brief Description
    Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1), demonstrating anticancer properties and applicable for studying relapsed/refractory multiple myeloma.
  • Description
    Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects.
  • In Vitro
    ——
  • In Vivo
    Animal Model:SCID mice injected with ARH-77 cells Dosage:20 mg/kg Administration:i.p.; twice-weekly; for 21 days Result:Significantly reduced tumor growth and prolonged animal survival.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1987854-08-9
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Niina Veitonm?ki, et al. A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo. Cancer Cell. 2013 Apr 15;23(4):502-15. ?
molnova catalog
related products
  • BIO-7662

    A potent, highly selective α4β1 integrin antagonist with Kd of <10 pM.

  • TBC3486

    A potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM.

  • OSU-T315

    A novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 uM.